Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Median pathway analysis by patient demographics, stage at diagnosis, route to diagnosis, and geography

The Cancer Alliance Data, Evidence and Analysis Service (CADEAS) have calculated the median time taken, in days, for patients to be seen for their first treatment following a referral, stratified by four intervals of the patient pathway.

These are:

  • Referral to first seen in secondary care
  • First seen in secondary care to diagnosis
  • Diagnosis to first multidisciplinary team (MDT) meeting
  • MDT meeting to treatment start date

This analysis is broken down by socio-demographic factors, stage at diagnosis, route to diagnosis, and geography, for patients diagnosed with one of fifteen cancers in the diagnosis years 2013 to 2018.

Click here to use this interactive tool to explore the variation in median pathway length by demographic factors and geography.
This website has been split up into three sections:

  • Overview - Provides a high-level summary of the variation in the median time taken for patients to be seen for their first treatment following a referral.
  • Demographic Factors - Provides analysis on the variation in the median time taken for patients to be seen for their first treatment following a referral, broken down by socio-demographic factors, cancer stage and routes to diagnosis, at Cancer Alliance level.
  • Geography - Provides analysis on the variation in the median time taken for patients to be seen for their first treatment following a referral, broken down by Cancer Alliance, STP and CCG.

This work is produced by the Cancer Alliance Data, Evidence and Analysis Service (CADEAS), a partnership between NHS England and NHS Improvement & Public Health England. It builds on work previously carried out by the NCRAS-TCST (National Cancer Registration and Analysis Service - Transforming Cancer Services Team for London) Partnership.

Data for this project is based on patient-level information collected by the NHS, as part of the care and support of cancer patients. The data is collated, maintained and quality assured by the National Cancer Registration and Analysis Service, which is part of Public Health England (PHE).

For queries regarding the tool, please contact england.cadeas@nhs.net